BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 20919802)

  • 1. Comment and reply on: Atorvastatin: safety and tolerability. Statins and polymyositis: a neglected link?
    Famularo G; Minisola G; Gasbarrone L
    Expert Opin Drug Saf; 2010 Nov; 9(6):1005-6; author reply 1006. PubMed ID: 20919802
    [No Abstract]   [Full Text] [Related]  

  • 2. Systemic infections can decrease the threshold of statin-induced muscle injury.
    Mahboobi SK; Shohat EZ; Jellinek SP; Rose M
    South Med J; 2006 Apr; 99(4):403-4. PubMed ID: 16634254
    [No Abstract]   [Full Text] [Related]  

  • 3. Atorvastatin-induced reversible positive antinuclear antibodies.
    Jiménez-Alonso J; Jaimez L; Sabio JM; Hidalgo C; Leon L
    Am J Med; 2002 Mar; 112(4):329-30. PubMed ID: 11893380
    [No Abstract]   [Full Text] [Related]  

  • 4. Myopathy after switching from brand to generic atorvastatin.
    Awoniyi O; Gosmanov AR
    J Am Geriatr Soc; 2013 Dec; 61(12):2254-2255. PubMed ID: 24329838
    [No Abstract]   [Full Text] [Related]  

  • 5. Autoimmune hepatitis revealed by atorvastatin.
    Pelli N; Setti M; Ceppa P; Toncini C; Indiveri F
    Eur J Gastroenterol Hepatol; 2003 Aug; 15(8):921-4. PubMed ID: 12867804
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-dose statins and the IDEAL study.
    Ravnskov U; Rosch PJ; Sutter MC
    JAMA; 2006 Jun; 295(21):2476; author reply 2478-9. PubMed ID: 16757714
    [No Abstract]   [Full Text] [Related]  

  • 7. High-dose statins and the IDEAL study.
    Cayley WE
    JAMA; 2006 Jun; 295(21):2476; author reply 2478-9. PubMed ID: 16757713
    [No Abstract]   [Full Text] [Related]  

  • 8. High-dose statins and the IDEAL study.
    Ong HT; Cheah JS
    JAMA; 2006 Jun; 295(21):2476-7; author reply 2478-9. PubMed ID: 16757712
    [No Abstract]   [Full Text] [Related]  

  • 9. Letter by Rosenberg and Uretsky regarding article, "Risks associated with statin therapy: a systematic overview of randomized clinical trials".
    Rosenberg L; Uretsky S
    Circulation; 2007 Jul; 116(1):e8; author reply e9. PubMed ID: 17606852
    [No Abstract]   [Full Text] [Related]  

  • 10. Summaries for patients. Muscle abnormalities in four patients taking statins to treat unfavorable cholesterol levels.
    Ann Intern Med; 2002 Oct; 137(7):I45. PubMed ID: 12353973
    [No Abstract]   [Full Text] [Related]  

  • 11. Regarding the mechanism of statin-induced myopathy.
    Noël B
    Am Heart J; 2005 Feb; 149(2):E3. PubMed ID: 15846246
    [No Abstract]   [Full Text] [Related]  

  • 12. Intensive lipid lowering with atorvastatin in coronary disease.
    Ravnskov U; Rosch PJ; Sutter MC
    N Engl J Med; 2005 Jul; 353(1):93-6; author reply 93-6. PubMed ID: 16003834
    [No Abstract]   [Full Text] [Related]  

  • 13. [Statin-induced dysphagia].
    Edholm B
    Ugeskr Laeger; 2010 Feb; 172(7):544-5. PubMed ID: 20156405
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atorvastatin-induced diaphragmatic muscle impairment.
    Sulem P; Bagheri H; Faixo Y; Montastruc JL
    Ann Pharmacother; 2001 Oct; 35(10):1292-3. PubMed ID: 11675865
    [No Abstract]   [Full Text] [Related]  

  • 15. Risk factors for rhabdomyolysis with simvastatin and atorvastatin.
    Golomb B; Evans M
    Drug Saf; 2006; 29(12):1191; author reply 1191-2. PubMed ID: 17147465
    [No Abstract]   [Full Text] [Related]  

  • 16. Atorvastatin-clopidogrel interaction.
    Martin PT; Denman R
    Circulation; 2003 Jun; 107(24):e223; author reply e223. PubMed ID: 12821599
    [No Abstract]   [Full Text] [Related]  

  • 17. [Proximal myopathy secondary to statin treatment in a patient with Hashimoto thyroiditis].
    Ferreiro JL; Dapena Mdel C; Suárez RL; Pérez-Argüelles BS; Vázquez CM
    Endocrinol Nutr; 2009; 56(7):387. PubMed ID: 19883901
    [No Abstract]   [Full Text] [Related]  

  • 18. Lack of adverse clopidogrel-atorvastatin clinical interaction.
    Saw J; Topol EJ
    Am J Cardiol; 2004 Mar; 93(5):669; author reply 669-70. PubMed ID: 14996608
    [No Abstract]   [Full Text] [Related]  

  • 19. The HMG Co-A reductase inhibitors ('statins') and myotoxic effects.
    S Afr Med J; 2002 Aug; 92(8):596-7. PubMed ID: 12244613
    [No Abstract]   [Full Text] [Related]  

  • 20. Does coenzyme-Q have a protective effect against atorvastatin induced myopathy? A histopathological and immunohistochemical study in albino rats.
    Khalil MS; Khamis N; Al-Drees A; Abdulghani HM
    Histol Histopathol; 2015 Mar; 30(3):383-90. PubMed ID: 25366571
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.